Top Markets
#1 DogBull DogBull +107.16%
#2 Siacoin Siacoin +55.09%
#3 ADO Protocol ADO Protocol +51.60%
#4 MarsCoin MarsCoin +44.94%
#5 The Bitcoin Bull The Bitcoin Bull +38.06%
#6 Ontology Gas Ontology Gas +23.11%
#7 Nockchain Nockchain +21.09%
#8 Apertum Apertum +20.23%
#9 Useless Coin Useless Coin +15.60%
#10 Rei Rei +12.65%
Coin of the day
DogBull DogBull
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
BioAge Labs Inc. BioAge Labs Inc.

BioAge Labs Inc.

BIOA
Classifica tra le azioni #15446
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops... BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Prezzo delle azioni
$9.42
Capitalizzazione di mercato
$354.69M
Variazione (1 giorno)
-0.83%
Variazione (1 anno)
91.09%
Paese
US
Scambia BioAge Labs Inc. (BIOA)

Categoria

Healthcare
Ricavi di BioAge Labs Inc. (BIOA)
Ricavi nel Sep 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di BioAge Labs Inc., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per BioAge Labs Inc. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH